427 related articles for article (PubMed ID: 32123729)
21. Facile fabrication of multi-pocket nanoparticles with stepwise size transition for promoting deep penetration and tumor targeting.
Hou X; Zhong D; Li Y; Mao H; Yang J; Zhang H; Luo K; Gong Q; Gu Z
J Nanobiotechnology; 2021 Apr; 19(1):111. PubMed ID: 33874945
[TBL] [Abstract][Full Text] [Related]
22. Enzyme-Induced Transformable Peptide Nanocarriers with Enhanced Drug Permeability and Retention to Improve Tumor Nanotherapy Efficacy.
Gong Z; Zhou B; Liu X; Cao J; Hong Z; Wang J; Sun X; Yuan X; Tan H; Ji H; Bai J
ACS Appl Mater Interfaces; 2021 Dec; 13(47):55913-55927. PubMed ID: 34784165
[TBL] [Abstract][Full Text] [Related]
23. A Near-Infrared Laser-Triggered Size-Shrinkable Nanosystem with In Situ Drug Release for Deep Tumor Penetration.
Wu D; Xu S; Zhang X; Li Y; Zhang W; Yan Q; Yang Q; Guo F; Yang G
ACS Appl Mater Interfaces; 2021 Apr; 13(14):16036-16047. PubMed ID: 33733732
[TBL] [Abstract][Full Text] [Related]
24. "Petal-like" size-tunable gold wrapped immunoliposome to enhance tumor deep penetration for multimodal guided two-step strategy.
Li Y; Song W; Hu Y; Xia Y; Li Z; Lu Y; Shen Y
J Nanobiotechnology; 2021 Sep; 19(1):293. PubMed ID: 34579725
[TBL] [Abstract][Full Text] [Related]
25. Chemical, physical, and biological stimuli-responsive nanogels for biomedical applications (mechanisms, concepts, and advancements): A review.
Bhaladhare S; Bhattacharjee S
Int J Biol Macromol; 2023 Jan; 226():535-553. PubMed ID: 36521697
[TBL] [Abstract][Full Text] [Related]
26. Nanoparticles for Cancer Targeting: Current and Future Directions.
Swain S; Sahu PK; Beg S; Babu SM
Curr Drug Deliv; 2016; 13(8):1290-1302. PubMed ID: 27411485
[TBL] [Abstract][Full Text] [Related]
27. Transformable nanodrugs for overcoming the biological barriers in the tumor environment during drug delivery.
Li X; Huang Z; Liao Z; Liu A; Huo S
Nanoscale; 2023 May; 15(19):8532-8547. PubMed ID: 37114478
[TBL] [Abstract][Full Text] [Related]
28. Recent Advances in Targeted Drug Delivery Strategy for Enhancing Oncotherapy.
Li J; Wang Q; Xia G; Adilijiang N; Li Y; Hou Z; Fan Z; Li J
Pharmaceutics; 2023 Aug; 15(9):. PubMed ID: 37765202
[TBL] [Abstract][Full Text] [Related]
29. A review of stimuli-responsive polymeric micelles for tumor-targeted delivery of curcumin.
Qiu N; Du X; Ji J; Zhai G
Drug Dev Ind Pharm; 2021 Jun; 47(6):839-856. PubMed ID: 34033496
[TBL] [Abstract][Full Text] [Related]
30. Recent Progress in Stimuli-Responsive Intelligent Nano Scale Drug Delivery Systems: A Special Focus Towards pH-Sensitive Systems.
Sethuraman V; Janakiraman K; Krishnaswami V; Kandasamy R
Curr Drug Targets; 2021; 22(8):947-966. PubMed ID: 33511953
[TBL] [Abstract][Full Text] [Related]
31. Stepwise targeted drug delivery to liver cancer cells for enhanced therapeutic efficacy by galactose-grafted, ultra-pH-sensitive micelles.
Yan G; Wang J; Hu L; Wang X; Yang G; Fu S; Cheng X; Zhang P; Tang R
Acta Biomater; 2017 Mar; 51():363-373. PubMed ID: 28087485
[TBL] [Abstract][Full Text] [Related]
32. Environmental stimulus-responsive mesoporous silica nanoparticles as anticancer drug delivery platforms.
Zhao H; Li Y; Chen J; Zhang J; Yang Q; Cui J; Shi A; Wu J
Colloids Surf B Biointerfaces; 2024 Feb; 234():113758. PubMed ID: 38241892
[TBL] [Abstract][Full Text] [Related]
33. pH-activatable polymeric nanodrugs enhanced tumor chemo/antiangiogenic combination therapy through improving targeting drug release.
Xiong H; Wu Y; Jiang Z; Zhou J; Yang M; Yao J
J Colloid Interface Sci; 2019 Feb; 536():135-148. PubMed ID: 30366179
[TBL] [Abstract][Full Text] [Related]
34. CREKA peptide-conjugated dendrimer nanoparticles for glioblastoma multiforme delivery.
Zhao J; Zhang B; Shen S; Chen J; Zhang Q; Jiang X; Pang Z
J Colloid Interface Sci; 2015 Jul; 450():396-403. PubMed ID: 25863222
[TBL] [Abstract][Full Text] [Related]
35. Tumor microenvironment remodeling-based penetration strategies to amplify nanodrug accessibility to tumor parenchyma.
Liu Y; Zhou J; Li Q; Li L; Jia Y; Geng F; Zhou J; Yin T
Adv Drug Deliv Rev; 2021 May; 172():80-103. PubMed ID: 33705874
[TBL] [Abstract][Full Text] [Related]
36. Bispyrene-Based Self-Assembled Nanomaterials: In Vivo Self-Assembly, Transformation, and Biomedical Effects.
He PP; Li XD; Wang L; Wang H
Acc Chem Res; 2019 Feb; 52(2):367-378. PubMed ID: 30653298
[TBL] [Abstract][Full Text] [Related]
37. Stimuli-responsive nanocarriers for drug delivery, tumor imaging, therapy and theranostics.
Mi P
Theranostics; 2020; 10(10):4557-4588. PubMed ID: 32292515
[TBL] [Abstract][Full Text] [Related]
38. MMP-2-Sensitive HA End-Conjugated Poly(amidoamine) Dendrimers via Click Reaction To Enhance Drug Penetration into Solid Tumor.
Han M; Huang-Fu MY; Guo WW; Guo NN; Chen J; Liu HN; Xie ZQ; Lin MT; Wei QC; Gao JQ
ACS Appl Mater Interfaces; 2017 Dec; 9(49):42459-42470. PubMed ID: 29143522
[TBL] [Abstract][Full Text] [Related]
39. Tumor pH-functionalized and charge-tunable nanoparticles for the nucleus/cytoplasm-directed delivery of oxaliplatin and miRNA in the treatment of head and neck cancer.
Lo YL; Lin HC; Tseng WH
Acta Biomater; 2022 Nov; 153():465-480. PubMed ID: 36115656
[TBL] [Abstract][Full Text] [Related]
40. Advances in mesoporous silica nanoparticles for targeted stimuli-responsive drug delivery.
Baeza A; Colilla M; Vallet-Regí M
Expert Opin Drug Deliv; 2015 Feb; 12(2):319-37. PubMed ID: 25421898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
